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How do these cells die? They 
perish through a specialized form 
of cell death that lacks hallmarks 
of apoptosis, as dying cells are 
negative for cleaved caspase-3, 
and do not exhibit condensed or 
fragmented nuclei. Instead, LAMP1, 
a lysosomal membrane protein, 
localizes around dying cells and 
acidification occurs at the earliest 
stages of death, suggesting 
lysosomal involvement.
How does entosis differ from 
other types of cell engulfment? 
Entosis should not be confused with 
phagocytosis, where dead, dying 
or pathogenic cells are engulfed. 
Phagocytosis is driven by cytoskeletal 
rearrangements within the host cell 
in response to signals given off by 
the target cell. In entosis, cells can 
be found inside apparently non-
phagocytic hosts and are internalized 
as viable cells. Also, the internalized 
cell appears to play a much more 
active role. Entosis thus more 
resembles parasite or pathogen cell 
invasion, or the process of leukocyte 
transcellular migration.
Is entosis seen in vivo? Reports 
of cells within cells date back to the 
early 1900s. Most homotypic cell-in-
cell structures are reported in human 
tumors. They are frequently found 
in exudates that contain metastatic 
carcinoma cells, or tumor samples 
harvested from urine. These fluid 
environments correspond to the  
in vitro conditions of matrix deprivation 
that promote entosis. The striking 
similarity to entotic structures 
suggests that entosis underlies the 
formation of cell-in-cell structures in 
many different tumors. Cell-in-cell 
structures have also been found in 
solid tumors. It is not known whether 
entosis is strictly a feature of tumor 
cells, or whether the process also 
occurs between normal cells  
in the body. 
How might entosis affect a tumor? 
As the main outcome of entosis 
is death of the internalized cell, it 
may represent a novel mechanism 
for eliminating cells outside of their 
normal microenvironment. This idea 
is supported by the observation 
that suppression of entosis, via 
inhibition of ROCK activity, increases 
anchorage-independent growth of 
cancer cells. However, this process 
is complex and the possible effects 
of entosis on tumor progression are 
currently under investigation.
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Figure 1. Formation of cells within cells by entosis. 
(A) A viable cell is internalized completely inside of another, forming a cell-in-cell structure (DIC 
image). The depicted cells are human mammary epithelial cells (MCF10A). (B) The fates of cells 
after entotic internalization. Extracellular 
regulation of BMP 
signaling
Lise Zakin and E.M. De Robertis*
In the developing organism, cells 
differentiate, divide and die as part of 
groups of hundreds or thousands of 
cells called ‘morphogenetic fields’. 
Fields have the remarkable property 
of self-regulation: for example, if 
the forelimb field is bisected, each 
half can give rise to a complete limb 
after transplantation, as discovered 
by Ross Harrison in 1918. Therefore, 
cells in the morphogenetic field are 
capable of long-range communication 
with each other in order to ascertain 
their position [1]. This positional 
information is relayed in the 
extracellular space in the form of 
concentration gradients of specific 
classes of extracellular molecules 
called ‘morphogens’ that trigger 
cellular responses by binding and 
activating cell surface receptors. Here, 
we focus on a family of morphogens 
called ‘Bone Morphogenetic Proteins’ 
(BMPs), which has provided a new 
paradigm for signaling regulation in 
the extracellular space. 
BMPs were discovered by Marshall 
Urist in 1965, who found that 
decalcified bone matrix fragments 
had bone-inducing activity when 
transplanted subcutaneously or 
intramuscularly into rats or rabbits. 
This activity was then solubilized 
and purified by Hari Reddi in 
1981, and in 1988 BMP2–7 were 
cloned [2]. BMPs belong to the 
Transforming Growth Factor β (TGF- β) 
superfamily, the most numerous 
group of growth factors in humans. 
During development, BMPs have 
been shown to participate in many 
signaling processes, including 
organogenesis, tissue type 
differentiation and dorsal-ventral 
patterning. In humans, altered BMP 
signaling is associated with cancer, 
skeletal and vascular diseases.
Binding of BMPs to cell 
membrane BMP receptors causes 
the phosphorylation and activation 
of transcription factors called 
‘Smad1/5/8’ inside the cell. The 
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action of an intricate network of 
secreted proteins that determine the 
concentration of active BMP ligands. 
In the frog Xenopus laevis, these 
secreted proteins include BMP-
binding molecules that behave 
as anti- or pro-BMPs and act by 
sequestering, transporting and 
solubilizing BMPs. This network 
of proteins has been conserved 
throughout the animal kingdom. 
Many of the Xenopus extracellular 
BMP regulators are also present 
in Drosophila, in which they also 
serve to generate a gradient 
of dorsal- ventral patterning 
information. These regulators include 
Chordin, Crossveinless-2 (CV2), 
Twisted Gastrulation (Tsg), Tolloid 
metalloproteinases that cleave 
and inactivate Chordin, Sizzled (a 
secreted Frizzled-related protein or 
sFRP) that is a competitive inhibitor 
of Tolloid metalloproteinases, the 
Ont-1 olfactomedin-related protein 
that promotes Chordin degradation, 
and Collagen IV, a component of 
the extracellular matrix that binds 
BMPs modifying their diffusion [1,3]. 
Ultimately, these extracellular factors 
regulate the flow of BMPs within 
the embryonic morphogenetic field 
toward regions that require peak 
BMP activity. The flow of growth 
factors is essential for the formation 
of a dorsal-ventral BMP gradient 
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Figure 1. The Chordin–BMP–Tsg–Tolloid–Ont-
1 complex.
Chordin–BMP–Tsg is a trimolecular inhibitory 
complex that prevents BMP from binding to 
its receptor (BMPR). Tolloid (scissors) cleaves 
Chordin at two specific sites, after CR1 and 
between CR3 and CR4. Ont-1 brings Chordin 
and Tolloid together, facilitating proteolysis. 
The olfactomedin domain of Ont-1 interacts 
with Chordin between CR2 and CR4, while its 
coiled-coil (C-C) domain binds to Tolloid.with its highest point in the ventral 
side of the Xenopus embryo, and for 
the long-range cell communications 
required for the self-regulating 
adjustments of the embryonic 
morphogenetic field. 
The components listed above, 
however, represent just the tip of 
the iceberg. Many other secreted 
BMP signaling antagonists have 
been discovered, such as Noggin, 
Follistatin (also an inhibitor of 
Activin), and members of the 
Cerberus/Gremlin/Coco/Dan family 
(which are multivalent BMP inhibitors 
that also affect other signaling 
factors such as Nodal and Wnts). 
Here, we concentrate on those 
components of the Chordin–BMP 
pathway that are known to interact 
genetically with BMPs in Drosophila 
or zebrafish studies, or that have 
been shown biochemically to bind 
to each other in the physiologically 
relevant, nanomolar range. It is 
likely that additional molecules 
will be added to this dorsal-ventral 
biochemical pathway in due course.
The Chordin–BMP pathway
Over the past decade, considerable 
progress has been made in 
understanding the biochemical 
function of extracellular BMP 
regulators during Xenopus dorsal-
ventral development. A central player 
is Chordin, a protein abundantly 
secreted in the dorsal side of 
the embryo. This region, called 
Spemann’s organizer, can induce a 
twinned axis after transplantation. 
Chordin is essential for this axis-
inducing activity, as depletion of 
Chordin with antisense morpholino 
oligos results in the loss of all 
inductive activity of Spemann’s 
organizer on neighboring cells [1]. 
BMPs are expressed both on the 
dorsal side of the embryo, where 
BMP2 and ADMP are secreted, 
and on the ventral side, which 
produces BMP4 and BMP7. 
Loss of Chordin results in the 
reduction of dorsal structures and 
expansion of ventroposterior tissues 
(ventralization). Depletion of all four 
BMPs causes the entire ectoderm 
to become brain tissue, indicating 
complete dorsalization.
Chordin contains four cysteine-rich 
domains (related to von Willebrand 
Factor C, vWF-c, domains) which 
bind BMPs, inhibiting BMP binding 
to their receptors (Figure 1). Inhibition is reversible, as active 
BMPs are released by Tolloid 
metalloproteinases that cleave 
Chordin at two specific sites. 
Tsg binds to both Chordin and 
BMP, facilitating the formation of 
Chordin–Tsg–BMP trimolecular 
complexes that can diffuse in the 
extracellular space. In this aspect 
of its function, Tsg is an anti-BMP. 
However, Tsg also has pro-BMP 
functions, as it serves to maintain 
BMPs, which have a strong tendency 
to bind to extracellular matrix 
proteins, in a soluble state. In 
zebrafish, knockdown of Tsg causes 
dorsalization, revealing that its 
pro- BMP effect prevails overall [1].
Sizzled, a protein secreted in a 
ventral region of the gastrulating 
Xenopus embryo called the ‘ventral 
center’, provides an additional 
layer of regulation (Figure 2). 
Sizzled inhibits the Tolloid protease, 
competing with its Chordin substrate 
for the protease’s active site. Sizzled 
and Chordin are secreted in similar 
amounts, but unlike Sizzled Chordin 
is secreted from the dorsal side of 
the embryo. In zebrafish, chordin 
or sizzled mutants have very similar 
loss-of-function phenotypes. Sizzled 
expression acts as a negative 
feedback inhibitor of BMP signaling 
in the ventral center. This is achieved 
indirectly by inhibition of Tolloid 
activity, which leads to increased 
levels of the BMP antagonist Chordin. 
Tolloid is also under direct negative 
feedback regulation by BMP (Figure 2). 
It has been recently found that 
BMP4 is a non-competitive inhibitor 
of Tolloid enzymatic activity [2]. In 
addition to a zinc metalloproteinase 
region, Tolloids contain five CUB 
domains and two EGF domains. 
BMP4 binds to individual CUB 
domains [2]. This binding provides 
the molecular explanation for an 
old mystery: when the first peptide 
sequences from extracts with bone-
inducing activity were obtained, 
BMP2 to BMP7 turned out to be 
growth factors, but the first protein 
identified, designated BMP1, 
corresponded to a Tolloid enzyme 
containing three CUB domains, which 
serve as BMP4/7 binding modules. A 
total of 53 other extracellular proteins 
in the human proteome contain CUB 
domains, raising the interesting 
possibility that many of these 
modules may function as BMP/TGF-β 
regulators.
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of the Chordin pathway is Ont1, 
a member of the olfactomedin 
family [4]. Olfactomedins contain 
two distinct domains, a coiled-coil 
and an olfactomedin domain. It 
was discovered that the coiled-coil 
domain of Ont1 binds Tolloid/BMP1, 
while its olfactomedin domain binds 
Chordin (Figure 1). Thus, Ont1 
functions as an extracellular scaffold 
protein that brings together Tolloid 
metalloproteinases and Chordin. 
Ont1 has a pro-BMP activity because 
it facilitates the degradation of 
Chordin. In the future, it will be 
interesting to ask whether other 
olfactomedins serve as scaffolds 
joining extracellular proteases and 
their substrates.
A role for the extracellular matrix
The extracellular matrix plays a role 
in formation of the BMP gradient. 
In Drosophila, type IV Collagen, a 
basement membrane collagen that 
is secreted into the perivitelline 
space of the blastoderm embryo, 
has been shown to bind the BMP2/4 
homologue Dpp [5]. Binding requires 
a short conserved sequence in 
the carboxy-terminal region of 
Drosophila and human Collagen 
IV. Dpp has been demonstrated 
to flow towards the dorsal side of 
the Drosophila embryo [6]. This 
transport requires both Short 
gastrulation (Sog), the homologue 
of Chordin, and Drosophila Tsg. 
Collagen IV in the extracellular 
matrix binds both Dpp and Sog, 
and in the presence of Tsg it 
greatly facilitates the formation of 
Sog–Tsg–Dpp complexes, 
which become soluble and are 
transported to the dorsal side. 
In evolutionary terms, the dorsal 
side of Drosophila is homologous 
to the ventral (high- BMP) side of 
vertebrates because an inversion of 
the dorsal-ventral axis took place 
during evolution [1]. As Collagen 
IV facilitates the flow of Dpp, its 
overall function is to promote 
peak levels of BMP signaling. This 
molecular mechanism is likely to be 
conserved in vertebrates, because 
binding of BMP4 to human type IV 
Collagen has been shown [5].
Crossveinless-2 provides a sink for 
Chordin–Tsg–BMP flow
A molecule that in recent years has 
captivated the attention of scientists in the BMP field is CV2. It was 
first identified in Drosophila as a 
mutation eliminating the formation 
of wing crossveins, structures that 
require high-BMP signaling. This 
suggested that CV2 would function 
as a pro-BMP. However, once the 
gene was cloned, initially by Seth 
Blair, both pro- and anti-BMP 
functions became evident. CV2 is 
a secreted protein containing five 
CR Chordin-like domains (Figure 3). 
The carboxyl terminus of CV2 has 
a vWF-d domain, which binds to 
heparan sulfate proteoglycans, 
such as glypicans attached to the 
plasma membrane via a Glycosyl-
Phosphatidyl-Inositol (GPI) 
hydrophobic anchor. This limits 
the ability of CV2 to diffuse in the 
extracellular space, so that it remains 
tethered to the cells in which it was 
produced. 
CV2 transcription is activated by 
high BMP signaling. In the Xenopus 
gastrula, CV2 is expressed in the 
ventral center. Like Chordin, it inhibits 
BMP signaling by binding to BMPs. 
In addition, CV2 triggers the clearing 
and inactivation of BMPs from the 
extracellular space through an 
endocytic trap mechanism. Therefore, 
in this aspect of its function, CV2 
serves as a BMP-feedback inhibitor 
(Figure 2).
How does the pro-BMP function 
of CV2 arise? Biochemical studies 
in Xenopus provided the molecular 
explanation: CV2 binds with high 
affinity to Chordin [7]. CV2 binds with 
even higher affinity to Chordin–BMP 
complexes, as well as to Chordin 
fragments generated by digestion 
with Tolloid protease. Thus, CV2 
tethered to the cell membrane of 
ventral cells serves as a molecular 
sink (Figure 3), concentrating 
Chordin–Tsg–BMP complexes made 
in more dorsal regions of the frog 
embryo. Once in the ventral side, 
BMPs are released from Chordin 
complexes by Tolloid digestion, 
allowing peak BMP signaling to take 
place. Therefore, CV2 has a pro-
BMP function because it promotes 
the flux of BMP morphogens to the 
region in which CV2 is expressed. 
Drosophila CV2 binds to the type 
I BMP receptor Thickveins as well 
as to Sog. The proximity between 
a cell surface BMP-binding protein 
and its BMP receptor may also 
help promote signaling at low 
CV2 levels [3].As most of the dissociation 
or enzymatic constants of this 
network of interacting extracellular 
proteins have been determined 
experimentally, the Chordin–Tsg–
BMP–Tolloid–CV2 pathway is ideally 
suited for mathematical modeling 
by reaction-diffusion equations 
[2]. Using this type of approach, 
it has been found that the flux of 
growth factors is essential to ensure 
robustness in the size adjustments 
embryonic morphogenetic fields 
must undergo after experimental 
manipulations [8]. In Drosophila, 
the crucial role played by the flux 
of Sog–Tsg–Dpp towards the site 
of peak BMP signaling has been 
documented in many modeling 
and experimental studies [3,6].
Self-regulation and transcriptional 
control
How does a Xenopus embryo re-form 
the entire body axis after being cut in 
half? The key to understanding this 
lies in the opposite transcriptional 
control of the dorsal and ventral 
centers. The transcription of ventral 
center genes is activated by BMP 
signaling (via Smad1/5/8 transcription 
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Figure 2. Self-regulation in Xenopus dorsal-
ventral patterning.
The pathway consists of a network of BMP-
interacting proteins. The diagram indicates 
extracellular biochemical protein–protein 
interactions as black arrows, transcriptional 
regulation under the control of BMP signaling 
as green arrows, and the directional flow of 
Chordin–BMP complexes from the dorsal to 
the ventral side of the embryo as red arrows.
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dorsal genes is repressed by BMP 
(Figure 2). 
A molecular see-saw is established, 
such that, for example, if BMP levels 
are lowered, BMP2 and ADMP 
levels increase in the dorsal center, 
restoring the gradient. If BMP levels 
increase, Sizzled levels rise, inhibiting 
BMP signaling indirectly through 
the inhibition of Tolloid enzyme 
activity and the consequent increase 
in the levels of the Chordin BMP 
antagonist (Figure 2). The Chordin–
BMP biochemical pathway is self-
adjusting due to a combination of 
intracellular transcriptional regulation 
and extracellular biochemical events 
that drive the flow of BMPs within 
the field [1].
Morphogenetic fields
Why is self-regulation of the BMP 
gradient so precisely regulated? In the 
case of Xenopus embryos, the egg is 
laid in a pond where temperature will 
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Figure 3. CV2–Chordin interaction.
Membrane-tethered CV2 serves as a sink for 
Chordin–Tsg–BMP on the ventral side of frog 
embryos. CV2 also interacts with the type I 
BMP transmembrane receptor (a serine/
threonine protein kinase that phosphorylates 
Smad1/5/8). This concentrates BMPs in the 
vicinity of their receptors once they have 
been released by Chordin after Tolloid cleav-
age (scissors). CV2 is also involved in the en-
docytosis of BMPs and possibly of Chordin 
and proteolytic Chordin fragments, removing 
them from the extracellular space.undoubtedly fluctuate. Mesodermal 
cells envelop the yolky endoderm, 
with the blastopore becoming ever 
smaller yet maintaining a constant 
gradient of BMP signaling. The 
ability of cells at opposite poles of 
the embryo to communicate over 
long distances — the frog gastrula 
contains about 10,000 cells — and 
to introduce self-adjustments, is an 
essential biological property. This 
is because the BMP morphogen 
gradient is responsible for histotypic 
differentiation in the embryo. For 
example, in the mesodermal germ 
layer, at the low end of the BMP 
gradient, prechordal plate and 
notochord differentiate. As BMP 
levels increase towards the ventral 
side, somite (muscle), kidney, lateral 
plate (body wall) and finally blood 
differentiation is elicited. The embryo 
gets only one chance to get allocation 
of its tissues right, and this has to be 
perfectly achieved time after time.
A very important outstanding 
question is whether the molecular 
mechanisms discovered in the 
morphogenetic field of early embryos 
also operate at later stages of 
development. Many self-regulating 
fields have been described by 
experimental embryologists — such 
as limb, heart, eye, lens, olfactory, 
and other organ-fields — but we do 
not know how any of these achieve 
self-regulation. One idea is that cells 
sense the positional information of 
their immediate neighbors, generating 
a system of polar coordinates that 
can explain many experimental 
observations in limb regeneration. 
Models in which physical morphogen 
gradients are maintained by the 
physicochemical flow of proteins 
within the organ-field would represent 
a significant departure from current 
wisdom. Yet, useful developmental 
circuits have a tendency to be used 
over and over in animals, not just in 
the embryo but also in the adult. 
One hint that protein flow might 
take place at later developmental 
stages comes from vertebral 
development in the mouse embryo. 
Knockout of CV2 in mice decreased 
BMP signaling in the intervertebral 
disc, even though CV2 protein 
is secreted and retained by 
prospective vertebral body cartilage 
[9]. Therefore, loss of CV2 has 
long-range effects in the vertebral 
morphogenetic field (about 85 
microns at embryonic day 12.5). It is possible that CV2 in cartilage may 
act as a sink for Chordin–Tsg–BMP4 
transported from the intervertebral 
disc. Chordin protein is secreted 
by intervertebral disc cells but 
accumulates in the vertebral body, 
and this flow of protein has a 
complete requirement for CV2. The 
long-range inhibition of Smad1/5/8 
phosphorylation [9] may be due to 
BMP inhibition caused locally by 
Chordin that is unable to flow towards 
its CV2 sink. Although a function 
for protein flow in later cell fields 
remains speculative, it is now clear 
that the Chordin–Tsg–BMP–Tolloid–
CV2 pathway, involving reciprocal 
transcriptional regulation at opposite 
poles and protein flow, constitutes 
the ancestral mechanism of dorsal-
ventral patterning. It determines 
dorsal-ventral positional information 
in the early morphogenetic field 
of embryos as diverse as those of 
Xenopus, zebrafish, amphioxus, 
hemichordates, spiders, beetles and 
Drosophila and presumably in most 
bilateral animals [1]. 
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